{"id":63511,"date":"2026-06-01T13:13:45","date_gmt":"2026-06-01T11:13:45","guid":{"rendered":"https:\/\/carlosoconnor.es\/?p=63511"},"modified":"2026-06-01T13:13:51","modified_gmt":"2026-06-01T11:13:51","slug":"resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos","status":"publish","type":"post","link":"https:\/\/carlosoconnor.es\/en\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/","title":{"rendered":"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Para quienes nos dedicamos a la medicina del sue\u00f1o, el manejo de la Apnea Obstructiva del Sue\u00f1o (AOS) siempre ha tenido un gran tal\u00f3n de Aquiles: la adherencia al tratamiento. Aunque la presi\u00f3n positiva continua (CPAP) sigue siendo el est\u00e1ndar de oro, un porcentaje cr\u00edtico de pacientes rechaza el dispositivo o es incapaz de tolerarlo a largo plazo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los resultados del ensayo cl\u00ednico SynAIRgy (NCT05813275), presentados recientemente en el Congreso Internacional de la American Thoracic Society (ATS) 2026 y publicados en el American Journal of Respiratory and Critical Care Medicine, prometen cambiar las reglas del juego mediante un abordaje farmacol\u00f3gico innovador: el AD109.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El AD109 es un comprimido de dosis fija que ataca directamente las causas fisiol\u00f3gicas del colapso de la v\u00eda a\u00e9rea superior durante el sue\u00f1o mediante la combinaci\u00f3n de dos principios activos:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; Atomoxetina: Un inhibidor de la recaptaci\u00f3n de norepinefrina (potencia la actividad noradren\u00e9rgica).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; Aroxibutinina: Un agente antimuscar\u00ednico (reduce la inhibici\u00f3n muscar\u00ednica).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Esta sinergia logra aumentar significativamente el tono de la musculatura de las v\u00edas respiratorias y disminuir su colapsabilidad durante la noche.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este hito nos encamina firmemente hacia la medicina personalizada del sue\u00f1o. Como se\u00f1ala el panel de expertos, el AD109 demostr\u00f3 eficacia cl\u00ednica principalmente en pacientes que presentaban apnea obstructiva sintom\u00e1tica al inicio del estudio. El futuro no consistir\u00e1 en sustituir radicalmente el CPAP, sino en dise\u00f1ar estrategias combinadas basadas en los fenotipos del paciente.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Enlaces:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; https:\/\/espanol.medscape.com\/viewarticle\/pastilla-fase-desarrollo-podr%C3%ADa-mejorar-apnea-2026a1000hkg<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; https:\/\/academic.oup.com\/ajrccm\/advance-article\/doi\/10.1093\/ajrccm\/aamag215\/8680221?login=false<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>#OSAeducation<\/strong> <strong>#SleepApnea<\/strong> <strong>#OSA<\/strong> <strong>#Innovaci\u00f3nM\u00e9dica<\/strong> <strong>#EnsayosCl\u00ednicos<\/strong> <strong>#SynAIRgy<\/strong> <strong>#AD109<\/strong> <strong>#CPAP<\/strong> <strong>#SaludDelSue\u00f1o<\/strong> <strong>#Neurolog\u00eda<\/strong> <strong>#Neumolog\u00eda<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"300\" height=\"168\" src=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg\" alt=\"images 2026 06 01T060239.368\" class=\"wp-image-63512\" style=\"width:625px;height:auto\" srcset=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg 300w, https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368-18x10.jpg 18w, https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368-270x152.jpg 270w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><figcaption class=\"wp-element-caption\">images 2026 06 01T060239.368<\/figcaption><\/figure>","protected":false},"excerpt":{"rendered":"<p>Para quienes nos dedicamos a la medicina del sue\u00f1o, el manejo de la Apnea Obstructiva del Sue\u00f1o (AOS) siempre ha tenido un gran tal\u00f3n de Aquiles: la adherencia al tratamiento.&hellip;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-63511","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS - Carlos O&#039;Connor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carlosoconnor.es\/en\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS - Carlos O&#039;Connor\" \/>\n<meta property=\"og:description\" content=\"Para quienes nos dedicamos a la medicina del sue\u00f1o, el manejo de la Apnea Obstructiva del Sue\u00f1o (AOS) siempre ha tenido un gran tal\u00f3n de Aquiles: la adherencia al tratamiento.&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carlosoconnor.es\/en\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\" \/>\n<meta property=\"og:site_name\" content=\"Carlos O&#039;Connor\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-01T11:13:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-01T11:13:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"168\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gestion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gestion\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\"},\"author\":{\"name\":\"gestion\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949\"},\"headline\":\"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS\",\"datePublished\":\"2026-06-01T11:13:45+00:00\",\"dateModified\":\"2026-06-01T11:13:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\"},\"wordCount\":315,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/carlosoconnor.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\",\"url\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\",\"name\":\"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS - Carlos O&#039;Connor\",\"isPartOf\":{\"@id\":\"https:\/\/carlosoconnor.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg\",\"datePublished\":\"2026-06-01T11:13:45+00:00\",\"dateModified\":\"2026-06-01T11:13:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage\",\"url\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg\",\"contentUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/carlosoconnor.es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/carlosoconnor.es\/#website\",\"url\":\"https:\/\/carlosoconnor.es\/\",\"name\":\"Carlos O&#039;Connor\",\"description\":\"Dr. Carlos O&#039;Connor Reina - Otorrinolaring\u00f3logo\",\"publisher\":{\"@id\":\"https:\/\/carlosoconnor.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/carlosoconnor.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/carlosoconnor.es\/#organization\",\"name\":\"Carlos O&#039;Connor\",\"url\":\"https:\/\/carlosoconnor.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png\",\"contentUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png\",\"width\":241,\"height\":50,\"caption\":\"Carlos O&#039;Connor\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949\",\"name\":\"gestion\",\"sameAs\":[\"https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025\"],\"url\":\"https:\/\/carlosoconnor.es\/en\/author\/gestion\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS - Carlos O&#039;Connor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carlosoconnor.es\/en\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/","og_locale":"en_GB","og_type":"article","og_title":"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS - Carlos O&#039;Connor","og_description":"Para quienes nos dedicamos a la medicina del sue\u00f1o, el manejo de la Apnea Obstructiva del Sue\u00f1o (AOS) siempre ha tenido un gran tal\u00f3n de Aquiles: la adherencia al tratamiento.&hellip;","og_url":"https:\/\/carlosoconnor.es\/en\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/","og_site_name":"Carlos O&#039;Connor","article_published_time":"2026-06-01T11:13:45+00:00","article_modified_time":"2026-06-01T11:13:51+00:00","og_image":[{"width":300,"height":168,"url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg","type":"image\/jpeg"}],"author":"gestion","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gestion","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#article","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/"},"author":{"name":"gestion","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949"},"headline":"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS","datePublished":"2026-06-01T11:13:45+00:00","dateModified":"2026-06-01T11:13:51+00:00","mainEntityOfPage":{"@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/"},"wordCount":315,"commentCount":0,"publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"image":{"@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg","articleSection":["Uncategorized"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/","url":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/","name":"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS - Carlos O&#039;Connor","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage"},"image":{"@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg","datePublished":"2026-06-01T11:13:45+00:00","dateModified":"2026-06-01T11:13:51+00:00","breadcrumb":{"@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#primaryimage","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2026\/06\/images-2026-06-01T060239.368.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/carlosoconnor.es\/resultados-positivos-del-ensayo-clinico-synairgy-nct05813275-en-el-abordaje-farmacologico-de-la-aos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/carlosoconnor.es\/"},{"@type":"ListItem","position":2,"name":"Resultados positivos del ensayo cl\u00ednico SynAIRgy (NCT05813275) en el abordaje farmacol\u00f3gico de la AOS"}]},{"@type":"WebSite","@id":"https:\/\/carlosoconnor.es\/#website","url":"https:\/\/carlosoconnor.es\/","name":"Carlos O&#039;Connor","description":"Dr. Carlos O&#039;Connor Reina - Otorrinolaring\u00f3logo","publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carlosoconnor.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/carlosoconnor.es\/#organization","name":"Carlos O&#039;Connor","url":"https:\/\/carlosoconnor.es\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","width":241,"height":50,"caption":"Carlos O&#039;Connor"},"image":{"@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949","name":"gestion","sameAs":["https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025"],"url":"https:\/\/carlosoconnor.es\/en\/author\/gestion\/"}]}},"_links":{"self":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/63511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/comments?post=63511"}],"version-history":[{"count":1,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/63511\/revisions"}],"predecessor-version":[{"id":63513,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/63511\/revisions\/63513"}],"wp:attachment":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/media?parent=63511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/categories?post=63511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/tags?post=63511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}